FindTrial
Sign In

The effect of Low molecular heparin or Bivalirudin on platelets during the use of Intra-Aortic Balloon Pumps

he effect of Low molecular heparin or Bivalirudin on platelets during the use of Intra-Aortic Balloon Pumps(IABP)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003607
Enrollment
Unknown
Registered
2013-08-27
Start date
2013-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The association of thrombocytopenia with the IABP

Interventions

A:the Low molecular heparin
B: Bivalirudin

Sponsors

Guangzhou Military Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patients with AMI were successfully implanted the IABP; 2. Men or women aged 18 to 80; 3. The patients agreed with the clinical trials and signed the informed consent before treatment.

Exclusion criteria

Exclusion criteria: 1. Always exist thrombocytopenia or coagulation dysfunction; 2. Hematocrit value less than 30 before IABP placement; 3. A platelet count<100,000/mL before IABP placement; 4. Use the extracorporeal membrane oxygenation(ECMO)and/or hemodialysis during the use of Intra-Aortic Balloon Pumps.

Design outcomes

Primary

MeasureTime frame
platelet parameters, hematolysis targets, bleeding targets, H-PT4;—

Countries

China

Contacts

Public ContactDingcheng Xiang
471397005@qq.com+86 15625052836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026